Decreased GCase activity in both GBA1-Parkinson’s patient neurons and GCase inhibitor-treated cells is associated with extended MLCs, elevated lysosomal pH, and mitochondrial dysfunction [30]. Here, GBA1 is linked to Parkinson disease.